Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument

2020 ◽  
pp. 1-10
Author(s):  
Philipp Maisch ◽  
Margitta Retz ◽  
Jürgen E. Gschwend ◽  
Florestan Koll ◽  
Sebastian C. Schmid
2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Thanansayan Dhivagaran ◽  
Umaima Abbas ◽  
Fahad Butt ◽  
Luckshann Arunasalam ◽  
Oswin Chang

Abstract Background In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 was identified as the cause of an acute respiratory disease, coronavirus disease 2019 (COVID-19). Given the lack of validated treatments, there is an urgent need for a high-quality management of COVID-19. Clinical practice guidelines (CPGs) are one tool that healthcare providers may use to enhance patient care. As such, it is necessary that they have access to high-quality evidence-based CPGs upon which they may base decisions regarding the management and use of therapeutic interventions (TI) for COVID-19. The purpose of the proposed study is to assess the quality of CPGs that make management or TI recommendations for COVID-19 using the AGREE II instrument. Methods The proposed systematic review will identify CPGs for TI use and/or the management of COVID-19. The MEDLINE, EMBASE, CINAHL, and Web of Science databases, as well as the Guidelines International Network, National Institute for Health and Clinical Excellence, Scottish Intercollegiate Guidelines Network, and the World Health Organization websites, will be searched from December 2019 onwards. The primary outcome of this study is the assessed quality of the CPGs. The quality of eligible CPGs will be assessed using the Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument. Descriptive statistics will be used to quantify the quality of the CPGs. The secondary outcomes of this study are the types of management and/or TI recommendations made. Inconsistent and duplicate TI and/or management recommendations made between CPGs will be compared across guidelines. To summarize and explain the findings related to the included CPGs, a narrative synthesis will also be provided. Discussion The results of this study will be of utmost importance to enhancing clinical decision-making among healthcare providers caring for patients with COVID-19. Moreover, the results of this study will be relevant to guideline developers in the creation of CPGs or improvement of existing ones, researchers who want to identify gaps in knowledge, and policy-makers looking to encourage and endorse the adoption of CPGs into clinical practice. The results of this review will be published in a peer-reviewed journal and presented at conferences. Systematic review registration International Prospective Register for Systematic Reviews (PROSPERO)—CRD42020219944


2021 ◽  
Author(s):  
Daniela Prócida Raggio ◽  
Rokaia Elagami ◽  
Claudia Jacqueline Lopez Gallegos ◽  
Tamara Tedesco ◽  
Thais Gimenez ◽  
...  

Clinical Practice Guidelines (CPGs) are recommendations for the health care providers and a method to close the know-do gap, transferring the knowledge from the academic research to the clinician. The proposal of this systematic review is to assess the quality of published guidelines regarding Pediatric Dentistry topics using AGREE II instrument and AGREE REX tool. This study is registered on Open Science Framework (OSF). Two examiners will independently search for literature based on the PICO question and will perform a screening of the literature according to inclusion and exclusion criteria, as well as data collection and extraction. The search will be performed in different electronic databases including Medline (PubMed), Embase, Scopus, LIVIVO, Caribbean Health Sciences Literature (Lilacs), Scientific societies, and International association websites (American Academy of Pediatric Dentistry - AAPD, European Academy of Pediatric Dentistry - EAPD, Guidelines International Network (GIN), National Institute for Health and Care Excellence – NICE, TRIP - Turning Research Into Practice database and Scottish Dental Clinical Effectiveness Programme - SDCEP), and grey literature (ProQuest) to identify any topic regarding Pediatric Dentistry guidelines. The search strategy for this systematic review will be defined through the PICO question: “Do the clinical practice guidelines and recommendations on pediatric dentistry meet the quality standards based on the AGREE II instrument and AGREE REX tool?”. We will include evidence-based and consensus-based guidelines that address any topic related to Pediatric Dentistry, and that report on the evidence level supporting each recommendation. We will exclude any outdated documents (when they have the updated version), topics irrelevant to Pediatric Dentistry, and duplicate publications. Inter-rater reliability (Intraclass correlation coefficient) will be calculated to ensure the level of agreement among researchers. For the assessment of eligible guidelines and recommendations, the AGREE II instrument and AGREE REX tool will be used in the complete form. Lastly, descriptive statistics and linear regression models will be conducted.


Heliyon ◽  
2020 ◽  
Vol 6 (12) ◽  
pp. e05612
Author(s):  
Jessica Arieta-Miranda ◽  
Abad Salcedo Alcaychahua ◽  
Gary Pereda Santos ◽  
Manuel Chávez Sevillano ◽  
Rosa Lara Verástegui ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. e048297
Author(s):  
Dana Yen Lin Lee ◽  
Romi Haas ◽  
Jason A Wallis ◽  
Denise A O’Connor ◽  
Rachelle Buchbinder

IntroductionShoulder conditions are a major cause of morbidity in the general population. Many clinical practice guidelines (CPGs) for shoulder conditions have been developed. Their purpose is to provide evidence-based recommendations to assist clinicians in providing optimal care to maximise patient outcomes. The aim of this systematic review is to identify, appraise, and compare the content and quality of CPGs for atraumatic shoulder conditions.Methods and analysisCPGs for atraumatic shoulder conditions will be included provided they make recommendations about diagnosis and/or management, are identified by their authors as a guideline and are consistent with the Appraisal of Guidelines for Research and Evaluation (AGREE) II definition of a guideline. A systematic search of electronic databases, online guideline repositories and the websites of relevant professional societies will be conducted to identify eligible CPGs. Search terms relating to shoulder conditions (eg, ‘adhesive capsulitis’, ‘rotator cuff’ and ‘bursitis’) will be combined with a validated search filter for CPGs. Pairs of independent reviewers will determine eligibility of CPGs identified by the search. Quality appraisal of included CPGs will be performed using the AGREE II instrument. Recommendations from each CPG and how they were determined will be extracted and compared across similar CPGs. Results from this systematic review will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement.Ethics and disseminationEthical approval is not required for this systematic review. The results from this study will be published in a peer-reviewed journal and disseminated to professional societies that publish shoulder CPGs, clinical policy groups, clinicians, researchers and consumers.PROSPERO registration numberCRD42020182723.


BMJ Open ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. e040182
Author(s):  
Meng Zhang ◽  
Jun Tang ◽  
Yang He ◽  
Wenxing Li ◽  
Zhong Chen ◽  
...  

ObjectiveHyperbilirubinemia is one of the most common clinical symptoms in newborns. To improve patient outcomes, evidence-based and implementable guidelines are required. However, clinical guidelines may vary in quality, criteria and recommendations among regions and countries. In this study, we aimed to systematically assess the quality of guidelines using the Appraisal of Guidelines for Research & Evaluation (AGREE)-II instrument and summarise the specific recommendations for neonatal hyperbilirubinemia in order to provide suggestions for future guideline development.DesignSystematic review.InterventionsWe searched the PubMed, Embase, Medline and guideline databases for relevant articles on 10 April 2020. The studies were screened by two independent reviewers according to our inclusion criteria. Two reviewers independently extracted the descriptive data. Four appraisers assessed the guidelines using the AGREE-II instrument.ResultsOur systematic review appraised 12 clinical practice guidelines for the diagnosis and management of neonatal hyperbilirubinemia. The 12 guidelines achieved an average score of 36%–89%. The guidelines received the highest scores for clarity of presentation and lowest scores for rigour of development. Most recommendations for diagnosis were relatively consistent, but recommendations regarding risk factors, the initiating threshold of treatment and pharmacotherapy varied.ConclusionsOur study revealed that current guidelines vary in the quality of the developing process and are inconsistent with regards to recommendations. Future guidelines should afford more attention to the quality of methodologies in guideline development, and more qualified evidence is needed to standardise the initiating threshold of treatment for neonatal hyperbilirubinemia.


Sign in / Sign up

Export Citation Format

Share Document